实施激励性规制推进我国医药产业改革与发展

The Reform and Development of Medicine Industry by Implementing Chinese Incentive Regulation

改革开放以来,我国医药产业有了较快的发展,产业基础有了很大的提升,但与世界上发达国家相比,仍存在着较大差距和问题。竞争是提高产业整体效率、改善社会整体福利的不可缺少的重要因素。激励性规制是在保持原有规制结构的条件下,激励受规制企业提高内部效率,给予受规制企业以竞争压力和提高生产或经营效率的正面诱因。我国医药产业可以通过实施激励性规制,推进改革与发展、调整产业结构、优化资源配置、提高国际竞争力。

Chinese medicine industry has scored a fast developmeng since the implementations of the policies of reform and opening to the outside world Though. the industrial foundation has been promoted greatly compared with developed countries in the world, there still exists substantial disparities and problems. Competition is the essentially important factor to enhance the industrial overall efficiency and improve the overall society welfare. The incentive regulation is to encourage the enterprises to improve the internal efficiency and give them competitive pressure and positive causes to promote production or the management efficiency. Chinese medicine industry need advance the reform and development, adjust industrial structure, optimize resources allocation, enhance international competitiveness by implementating incentive regulation.